Highlights Iris Acquisition Corp

Equities

IRAA

US89601Y1010

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-31 pm EDT			5-day change	1st Jan Change
11.96 ^USD	+10.74%		+13.80%	+15.78%

May. 23	Iris Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 17	Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Iris Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 23	CI
Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 17	CI
Iris Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Jan. 12	CI
Iris Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Iris Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
IRIS ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-18	AQ
Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-18	CI
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp	22-12-06	AQ
Iris Acquisition : Businesses announce Definitive Business Combination Agreement and plan to operate under Liminatus Pharma - Form 8-K	22-12-01	PU
IRIS ACQUISITION CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-12-01	AQ
Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal	22-12-01	MT
Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments	22-11-30	BU
Liminatus Pharma, LLC entered into a definitive business combination agreement to acquire Iris Acquisition Corp from Iris Acquisition Holdings LLC and others for approximately $250 million in a reverse merger transaction.	22-11-30	CI
IRIS ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-21	AQ
Iris Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
IRIS ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-19	AQ
Iris Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-19	CI
Tribe Capital Growth I : Announces Name Change to Iris Acquisition Corp and Other Management Changes - Form 8-K	22-07-27	PU
TRIBE CAPITAL GROWTH CORP I Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-05-23	AQ
Tribe Capital Growth Corp I Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Iris Acquisition Corp

Equities

IRAA

US89601Y1010

Highlights

Filters